Violeta Popovici (15 results)

Hardback or Cased Book. Condition: New. Oral Cancer: Prophylaxis, Etiopathogenesis and Treatment. Book.

HRD. Condition: New. New Book. Shipped from UK. Established seller since 2000.

HRD. Condition: New. New Book. Shipped from UK. Established seller since 2000.

HRD. Condition: New. New Book. Shipped from UK. Established seller since 2000.

HRD. Condition: New. New Book. Shipped from UK. Established seller since 2000.

Hardcover. Condition: new. Hardcover. Cancer remains one of the leading causes of death worldwide, particularly in countries with higher life expectancy, education levels, and standards of living, despite significant advances in early detection and treatment over recent decades. As a result, there is growing interest in exploring alternative and complementary strategies, such as the use of natural compounds as adjuvant therapies, to improve patient outcomes.The plant world has emerged as a rich source of bioactive molecules for the discovery and development of new anticancer drugs. Several plant metabolites have served as lead structures for the development of FDA-approved chemotherapeutics. Research into medicinal plants continues to grow because novel therapeutics derived from them offer the promise of more effective, less toxic treatment options for patients, particularly when conventional therapies are limited by resistance or intolerable side effects. Plant extracts and isolated phytochemicals have demonstrated strong potential to improve the clinical outcomes of cancer patients, as evidenced by a growing body of preclinical and clinical research. In addition to direct cytotoxic effects, many phytochemicals modulate key signaling pathways involved in tumor growth, metastasis, and immune evasion. They may enhance the sensitivity of cancer cells to existing treatments. This item is printed on demand. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.

Condition: New. Print on Demand.

Condition: New. Print on Demand.

Condition: New. PRINT ON DEMAND.

Hardcover. Condition: new. Hardcover. Cancer remains one of the leading causes of death worldwide, particularly in countries with higher life expectancy, education levels, and standards of living, despite significant advances in early detection and treatment over recent decades. As a result, there is growing interest in exploring alternative and complementary strategies, such as the use of natural compounds as adjuvant therapies, to improve patient outcomes.The plant world has emerged as a rich source of bioactive molecules for the discovery and development of new anticancer drugs. Several plant metabolites have served as lead structures for the development of FDA-approved chemotherapeutics. Research into medicinal plants continues to grow because novel therapeutics derived from them offer the promise of more effective, less toxic treatment options for patients, particularly when conventional therapies are limited by resistance or intolerable side effects. Plant extracts and isolated phytochemicals have demonstrated strong potential to improve the clinical outcomes of cancer patients, as evidenced by a growing body of preclinical and clinical research. In addition to direct cytotoxic effects, many phytochemicals modulate key signaling pathways involved in tumor growth, metastasis, and immune evasion. They may enhance the sensitivity of cancer cells to existing treatments. This item is printed on demand. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.

Hardcover. Condition: new. Hardcover. Cancer remains one of the leading causes of death worldwide, particularly in countries with higher life expectancy, education levels, and standards of living, despite significant advances in early detection and treatment over recent decades. As a result, there is growing interest in exploring alternative and complementary strategies, such as the use of natural compounds as adjuvant therapies, to improve patient outcomes.The plant world has emerged as a rich source of bioactive molecules for the discovery and development of new anticancer drugs. Several plant metabolites have served as lead structures for the development of FDA-approved chemotherapeutics. Research into medicinal plants continues to grow because novel therapeutics derived from them offer the promise of more effective, less toxic treatment options for patients, particularly when conventional therapies are limited by resistance or intolerable side effects. Plant extracts and isolated phytochemicals have demonstrated strong potential to improve the clinical outcomes of cancer patients, as evidenced by a growing body of preclinical and clinical research. In addition to direct cytotoxic effects, many phytochemicals modulate key signaling pathways involved in tumor growth, metastasis, and immune evasion. They may enhance the sensitivity of cancer cells to existing treatments. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.

Buch. Condition: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Oral cancer contributes to approximately 3-10% of all cancer mortality worldwide, and its incidence is continuously increasing due to environmental conditions and harmful modern lifestyles. In association with hereditary predisposition, chronic inflammation, and infectious diseases, these factors raise the frequency of oral cavity malignancies. Oral squamous cell carcinoma (OSCC) represents 90% of oral neoplasia; it is the sixth most frequent malignancy in the world, with an overall 5-year survival rate below 50% due to its modest outcomes, late diagnosis, aggressive local invasiveness, recurrences, and metastases. OSCC belongs to the comprehensive group of head and neck squamous cell carcinomas (HNSCCs), which affect the cell lining of the oral cavity, pharynx, and larynx. The local-regional recurrence rate for advanced carcinomas is over 50% despite the administration of multimodal therapy, and understanding the biology of HNSCCs is essential to ameliorate their prognosis. A major intervention involves extensive surgery associated with radio and chemotherapy. Advancements in cancer immunotherapy have not yet established the specific mechanisms by which immune cells influence tumor progression and immune evasion, and oral cancers continue to respond inadequately to the current treatment protocols. The above-mentioned aspects underline this Special Issue, which has brought together the most recent research on molecular mechanisms implied in the prophylaxis, etiopathogenesis, diagnosis, treatment, evolution, and prognosis of oral cancer.

Buch. Condition: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Cancer remains one of the leading causes of death worldwide, particularly in countries with higher life expectancy, education levels, and standards of living, despite significant advances in early detection and treatment over recent decades. As a result, there is growing interest in exploring alternative and complementary strategies, such as the use of natural compounds as adjuvant therapies, to improve patient outcomes.The plant world has emerged as a rich source of bioactive molecules for the discovery and development of new anticancer drugs. Several plant metabolites have served as lead structures for the development of FDA-approved chemotherapeutics. Research into medicinal plants continues to grow because novel therapeutics derived from them offer the promise of more effective, less toxic treatment options for patients, particularly when conventional therapies are limited by resistance or intolerable side effects. Plant extracts and isolated phytochemicals have demonstrated strong potential to improve the clinical outcomes of cancer patients, as evidenced by a growing body of preclinical and clinical research. In addition to direct cytotoxic effects, many phytochemicals modulate key signaling pathways involved in tumor growth, metastasis, and immune evasion. They may enhance the sensitivity of cancer cells to existing treatments.

Buch. Condition: Neu. Oral Cancer | Prophylaxis, Etiopathogenesis and Treatment | Buch | Englisch | 2025 | MDPI AG | EAN 9783725830152 | Verantwortliche Person für die EU: Libri GmbH, Europaallee 1, 36244 Bad Hersfeld, gpsr[at]libri[dot]de | Anbieter: preigu Print on Demand.

Buch. Condition: Neu. Advances in Plant-Sourced Natural Compounds as Anticancer Agents | Buch | Englisch | 2026 | MDPI AG | EAN 9783725864508 | Verantwortliche Person für die EU: Libri GmbH, Europaallee 1, 36244 Bad Hersfeld, gpsr[at]libri[dot]de | Anbieter: preigu Print on Demand.